Intellia Therapeutics
Brittany Chaves is a seasoned professional in investor relations and corporate communications, currently serving as a Senior Manager of Investor Relations at Intellia Therapeutics, Inc. since June 2021, following a tenure as Manager in the same department. Previously, Brittany held roles at Agios Pharmaceuticals, where responsibilities included managing logistics for investor and public relations events and developing press materials. With a background in sales and marketing at organizations such as EF Education First and Starwood Hotels & Resorts, Brittany has demonstrated expertise in brand development, client management, and event coordination. Brittany holds a Bachelor's degree in Hospitality Management from Endicott College.
This person is not in any teams
This person is not in any offices
Intellia Therapeutics
9 followers
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.